Abstract
Our understanding of tumorigenesis and cancer progression as well as clinical therapies for different cancer types have evolved dramatically in recent years. However, even with this progress, there are big challenges for scientists and oncologists to tackle, ranging from unpacking the molecular and cellular mechanisms involved to therapeutics and biomarker development to quality of life in the aftermath of therapy. In this article, we asked researchers to comment on the questions that they think are important to address in the coming years.
Original language | English (US) |
---|---|
Pages (from-to) | 1523-1527 |
Number of pages | 5 |
Journal | Cell |
Volume | 186 |
Issue number | 8 |
DOIs |
|
State | Published - Apr 13 2023 |
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology